Publications 2023

  1. Camoni L, Santos A, Luporsi M, Grilo A, Pietrzak A, Gear J, Zucchetta P, Bar-Sever Z. EANM procedural recommendations for managing the paediatric patient in diagnostic nuclear medicine. Eur J Nucl Med Mol Imaging, 50:3862-3879, 2023. DOI: doi: 10.1007/s00259-023-06357-3 

  2. Beddok A, Mouren V, Cottu P, Laki F, Fourquet A, Kirova Y. Outcomes and toxicity of concurrent CDK4/6 inhibitor and locoregional radiotherapy for patients with de novo metastatic breast cancer. Int J Cancer. 153(7):1386-1396, 2023. DOI: 10.1002/ijc.34562.  

  3. Beddok A, Chabi-Charvillat ML, Kennel T, de Wolf J, Pricopi C, Crequit P, Girard N, Otz J, Vallée A, Longchampt E, Sage E, Glorion M. Prospective Radiologic-Pathologic Correlation of Macroscopic Volume and Microscopic Extension of Nonsolid Lung Nodules on Thin-section CT Images for Sublobar Resection and Stereotactic Radiotherapy Planning. Clin Lung Cancer. 24(2):98-106, 2023. DOI: 10.1016/j.cllc.2022.11.001

  4. Schneider T, Malaise D, Pouzoulet F, Prezado Y. Orthovoltage X-ray Minibeam Radiation Therapy for the Treatment of Ocular Tumours-An In Silico Evaluation. Cancers (Basel). 15(3):679, 2023. DOI: 10.3390/cancers15030679

  5. Beddok A, Scher N, Alapetite C, Baussart B, Bentahila G, Bielle F, Bolle S, Dendale R, Dureau S, Goudjl F, Helfre S, Mammar H, Nichelli L, Calugaru V, Feuvret L. Proton therapy for adult craniopharyngioma: Experience of a single institution in 91 consecutive patients. Neuro Oncol. 25(4):710-719, 2023. DOI: 10.1093/neuonc/noac210.

  6. Deut U, Ronga MG, Bonfrate A, De Marzi L. Secondary radiation dose modeling in passive scattering and pencil beam scanning very high energy electron (VHEE) radiation therapy. Med Phys, 50(7):4491–4504, 2023. DOI: https://doi.org/10.1002/mp.16443

  7. Ronga MG, Deut U, Bonfrate A, De Marzi L. Very high-energy electron dose calculation using multiple scattering theory and a simplified pencil beam model. Med Phys, 1-14, 2023. DOI: https://doi.org/10.1002/mp.16697

  8. Flynn S, Allport P, De Marzi L, Green S, Homer M, Lee N, Ortiz R, Patriarca A, Prezado Y, Thomas R, Price T. Development of CMOS dosimetry in proton minibeams for enhanced QA and primary standard absorbed dose calorimetry. JINST, 8: P03014, 2023. DOI: https://doi.org/10.1088/1748-0221/18/03/P03014

  9. Leite AMM, Bonfrate A, Da Fonseca A, Lansonneur P, Alapetite C, Mammar H, De Marzi L. Double scattering and pencil beam scanning Monte Carlo workflows for proton therapy retrospective studies on radiation-induced toxicities. Cancer Radiother, S1278-3218(23)00070-7, 2023. DOI: https://doi.org/10.1016/j.canrad.2023.02.001

  10. Loap P, Barcellini A, De Marzi L, Orlandi E, Kirova Y. Neutron brachytherapy in the modern era: Indications and evidence. Cancer Radiother, 27(2):170–177, 2023. DOI: https://doi.org/10.1016/j.canrad.2022.08.010

  11. Seban RD, Arnaud E, Loirat D, Cabel L, Cottu P, Djerroudi L, Hescot A, Loap P, Bonneau C, Bidard FC, Huchet V, Jehanno N, Berenbaum A, Champion L, Buvat I. [18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab. Eur J Nucl Med Mol Imaging, 50:4024-4035, 2023.

  12. Malhaire C, Selhane F, Saint-Martin MJ, Cockenpot V, Akl P, Laas E, Bellesoeur A, Ala-Eddine C, Bereby-Kahane M, Manceau J, Sebbag-Sfez D, Pierga JY, Reyal F, Vincent-Salomon A, Brisse H, Frouin F. Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy. Eur Radiol, 33:8142-8154, 2023.

  13. Beddok A, Maynadier X, Krhili S, Ala Eddine C, Champion L, Chilles A, Goudjil F, Zefkili S, Amessis M, Choussy O, Le Tourneau C, Buvat I, Créhange G, Carton M, Calugaru V. Predictors of toxicity after curative reirradiation with intensity modulated radiotherapy or proton therapy for recurrent head and neck carcinoma: new dose constraints for pharyngeal constrictors muscles and oral cavity. Strahlenther Onkol,199:901-909, 2023.

  14. Kocak B, Baessler B, Bakas S, Cuocolo R, Fedorov A, Maier-Hein L, Mercaldo N, Müller H, Orlhac F,  Pinto dos Santos D, Stanzione A, Ugga L, Zwanenburg A. CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers. Insights into Imaging, 14(1):75, 2023. DOI: 10.1186/s13244-023-01415-8

  15. Buvat I, Weber W. Nuclear Medicine from a Novel Perspective: Buvat and Weber Talk with OpenAI's ChatGPT. J Nucl Med. 64:505-507, 2023. DOI: 10.2967/jnumed.123.265636

  16. Khalid F, Goya-Outi J, Escobar T, Dangouloff-Ros V, Grigis A, Philippe C, Boddaert N, Grill J, Frouin V, Frouin F. Multimodal MRI radiomic models to predict genomic mutations in diffuse intrinsic pontine glioma with missing imaging modalitie. Front Med, 10:1071447, 2023, DOI: 10.3389/fmed.2023.1071447.

  17. Nanni C, Kobe C, Baessler B, Baues C, Boellaard R, Borchmann P, Buck A, Buvat I, Chapuy B, Cheson B, Chrzan R, Cottereau AS, Dührsen U, Eikenes L, Hutchings M, Jurczak W, Kraeber-Bodéré F, Kopci E, Luminari S, MacLennan S, Mikhaeel G, Nijland M, Rodriguez-Otero P, Treglia G, Withofs N, Zamagni E, Zinzani PL, Zijlstra JM, Herrmann K, Kunikowska J. EANM Focus 4: Consensus on molecular imaging and therapy in haematological tumors. Lancet Haematol, 10(5):e367-e381, 2023. DOI: 10.1016/S2352-3026(23)00030-3. 

  18. Saboury B, Bradshaw T, Boellaard R, Buvat I, Dutta J, Hatt M, Jha AK, Li Q, Liu C, McMeekin H, Morris MA, Scott PJH, Siegel E, Sunderland JJ, Wahl RL, Zuehlsdorff S, Rahmim A. Toward Trustworthy Artificial Intelligence Ecosystems: Opportunities, Challenges, and Responsibilities in Nuclear Medicine. J Nucl Med, 64:188-196, 2023. DOI: 10.2967/jnumed.121.263703.  

  19. Rahimpour M, Saint Martin MJ, Frouin F, Akl P, Orlhac F, Koole M, Malhaire C. Visual ensemble selection of deep convolutional neural networks for 3D segmentation of breast tumors on dynamic contrast enhanced MRI. Eur Radiol, 33(2):959-969, 2023. DOI: 10.1007/s00330-022-09113-7

  20. Beddok A, Orlhac F, Calugaru V, Champion L, Ala Eddine C, Nioche C, Crehange G, Buvat I. [18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer. Eur J Nucl Med Mol Imaging, 50(2):559-571, 2023. DOI: 10.1007/s00259-022-06000-7

  21. Ortiz R, Belshi R, De Marzi L, Prezado Y. Proton minibeam radiation therapy for treating metastases: a treatment plan study. Medical Physics, 10.1002/mp.16203, 2023. DOI: 10.1002/mp.16203

  22. Leite AMM, Cavallone M, Ronga MG, Trompier F, Patriarca A, De Marzi L. Ion recombination correction factors and benchmark of detectors in a very-high dose rate proton scanning beam. Physica Medica, 106:102518, 2023. DOI: https://doi.org/10.1016/j.ejmp.2022.102518

  23. Iturri L, Bertho A, Lamirault C, Juchaux M, Gilbert C, Espenon J, Sebrie C, Jordain L, Pouzoulet F, Verrelle P, de Marzi L, Prezado Y. Proton flash therapy and immune infiltration: evaluation in an orthotopic glioma rat model. Int J Rad Oncol Biol Physics, 116:655-665, 2023. DOI: https://doi.org/10.1016/j.ijrobp.2022.12.018

  24. Guardiola C, Bachiller-Perea D, Kole EMM, Fleta C, Quirion D, De Marzi L, Gómez F. First experimental measurements of 2D microdosimetry maps in proton therapy. Med Phys. 50(1):570-581, 2023. DOI: 10.1002/mp.15945